This topic contains a solution. Click here to go to the answer

Author Question: The major value-creating capabilities of the organization are known as its ________. A) strengths ... (Read 43 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
The major value-creating capabilities of the organization are known as its ________.
 
  A) strengths
  B) competitive advantages
  C) core competencies
  D) resources

Question 2

Helen, the owner of Crazy Cupcakes, is conducting a SWOT analysis of her company. Which of the following represents an opportunity for expansion?
 
  A) There has been a trend toward personalized cupcakes for a variety of occasions.
  B) The production process was found to be highly efficient and wastage was kept to a minimum.
  C) In a taste test, Crazy Cupcakes products ranked higher than competitors in the taste and texture segments.
  D) One of Crazy Cupcakes competitors has added cookies to its product line.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

phuda

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A





 

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

For a complete list of videos, visit our video library